Skip to content

Study to check the safety and benefits of medicine Bisoprolol in Heart disease patients

Post Approval Concurrent Observational Study to Assess Safety Clinical Utilization and Effectiveness of BISOprolol in the treatment of Coronary ARtery Disease undergoing PCI(BISOCARD Study) - BISOCARD Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/049287
Enrollment
3000
Registered
2023-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I999- Unspecified disorder of circulatory system

Interventions

None listed

Sponsors

Torrent Pharmaceuticals Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Male or female patients 18 to 59 years 2 Known CAD cases requiring Bisoprolol 3 Known CAD cases with Comorbidities such as Hypertension or Diabetes 4 Patients willing follow up for 24 week at the same centre

Exclusion criteria

Exclusion criteria: 1 Hypersensitivity to Bisoprolol 2 Acute heart failure or during episodes of heart failure decompensation requiring IV Inotropic therapy 3 Cardiogenic shock 4 Second or third degree AV block 5 Sick sinus syndrome 6 Hepatic enzyme elevation X3 ULN 7 For women only currently pregnant confirmed with positive pregnancy test or breast feeding 8 Sexually active woman of childbearing age not practicing accepted birth control method

Design outcomes

Primary

MeasureTime frame
1 Mean changes from baseline in Heart Rate HR and Left Ventricular ejection fraction LVEF level at 24 weekTimepoint: 1 Baseline day 0 to 24 week

Secondary

MeasureTime frame
1 Proportion of participants with treatment emergent adverse event during observation period 2 Change for HR and LVEF in CAD cases with Hypertension at 24 week 3 Change in Blood pressure at 24 weekTimepoint: 1 Baseline Day 0 and 24 weeks 2 Baseline Day 0 and 24 weeks 3 Baseline Day 0 and 24 weeks

Countries

India

Contacts

Public ContactDr Krishnaprasad K

Swarna Heart Clinic

bpiifc@gmail.com9820054913

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026